The GLP-1 Saga Is Just Getting Started
Derek Lowe, Science Magazine Keeping up with the GLP-1 area is a full time job by itself. First off, you have the recent development that these drugs are no longer considered to officially…
Forget Ozempic, scientists find a microbe that can work like a natural alternative to popular diabetes and weight loss drug
Researchers in China have found a gut microbe, Bacteroides vulgatus, that may regulate blood sugar. The microbe and its metabolites can stimulate GLP-1 secretion. GLP-1 is a hormone that controls blood sugar and fullness. The study showed that increasing this microbe in mice can help. This discovery may offer a natural alternative to drugs like […]
GLP-1 RA Use for Obesity Soars Among Nondiabetic US Adults
Between 2018 and 2022, GLP-1 RA use surged among US adults without diabetes, yet adoption remained modest. Medscape Medical News
Warning over brutal & ‘super common’ Ozempic side effect that happens ‘overnight’ & makes users look ‘20 years older’
NAUSEA, constipation, breathing problems, racing heart… the list of Ozempic side effects appears to be growing by the day. And now experts have revealed a new “incredibly common” issue that “nearly everyone” using weight loss injections will experience. instagramCelebrities including Gemma Collins and Rebel Wilson have proudly confessed to using skinny jabs to shed the […]
FDA Accepts Filing Application for Oral Semaglutide 25 mg, Which If Approved, Would Be The First Oral GLP-1 Treatment for Obesity
PLAINSBORO, N.J., May 2, 2025 /PRNewswire/ — Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy®…
Review Article – GLP-1-Based Therapies for Diabetes, Obesity and Beyond
by Daniel J Drucker Nature Reviews Drug Discovery Drucker DJ. GLP-1-based therapies for diabetes, obesity and beyond. Nat Rev Drug Discov. 2025 Apr 25. doi: 10.1038/s41573-025-01183-8. Epub ahead of print. PMID: 40281304. This review article discusses GLP-1-based therapies, highlighting their effectiveness for managing type 2 diabetes and obesity, including well-known drugs like semaglutide and tirzepatide. The text details the evolution […]
‘Ozempic Mouth,’ ‘Feet’ Are Latest Names For GLP-1 Med Side Effects
You may have heard of “Ozempic face” and “Ozempic butt.” Well, now there’s “Ozempic mouth” and “Ozempic feet” to describe more effects of GLP-1 receptor agonists.
New GLP-1 Survey Finds Users Cutting Restaurant Spend
New GLP-1 Survey Finds Users Cutting Restaurant Spend Last week’s GLP-1 headlines included Novo Nordisk partnering with telehealth platforms Hims & Hers, LifeMD, and Ro to offer its weight-loss drug Wegovy directly to consumers at substantial discounts, aiming to improve affordability and access. Meanwhile, Eli Lilly reported robust demand for its rival anti-obesity medication, Mounjaro. […]